What have we learned in the past year, and how should industry proceed in 2020?
Where do hemp and cannabinoid companies fit in the manufacturing standards regimen? This has become the question in the absence of clear FDA guidance and regulations for manufacturing.
Analytical testing and regulatory experts advise on how to test for CBD quality.
What is CBD’s regulatory status, and how should companies proceed with caution? Leading industry regulatory consultants chime in.
The authors write: “It seems that foods and beverages containing CBD are likely to remain high-risk, while dietary supplements would appear to be a slightly lower-risk option for manufacturers or distributors of CBD-containing products.”
What’s the best way to ensure a GRAS notification for an ingredient’s use in medical foods will receive a “No Questions” letter from FDA?